Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
canakinumab (ilaris) (1 trial)
Muscular Dystrophies (Phase 2)
Muscular Dystrophy, Duchenne (Phase 2)
Trials (1 total)
Trial APIs (1 total)